Ahs Cancer Control Alberta

This study is testing if adding a precise, high-dose radiation treatment (SBRT) to standard chemotherapy and immunotherapy helps people with esophageal cancer that has spread to a few other places in the body. It aims to better control the cancer and help patients live longer wit…

This study is testing whether a less aggressive approach to lowering TSH hormone levels works as well as the current standard for controlling advanced thyroid cancer. Researchers will compare keeping TSH very low versus allowing slightly higher levels in 70 patients with cancer t…

This study is testing whether adding the drug olaparib to the chemotherapy temozolomide works better than temozolomide alone to control advanced triple-negative breast cancer. It will enroll 40 patients whose cancer has a specific genetic feature (MGMT methylation) and has worsen…

This study is testing whether giving immunotherapy in the morning makes it work better for people with advanced lung cancer. 58 participants will either receive their pembrolizumab infusions between 8-10 AM or at random times throughout the day. Researchers want to see if this si…

This is a single-patient study for someone with advanced alveolar soft part sarcoma, a rare cancer, that has progressed despite other treatments. The study will test a personalized therapy called GCAR1, which involves modifying the patient's own immune cells to attack their cance…

This study is for men with high-risk prostate cancer that hasn't spread to their lymph nodes. It compares two ways of giving radiation therapy: targeting just the prostate versus also treating the entire pelvic area. Doctors will use a special PSMA scan to get a clearer picture o…